about
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Ico...
Read More
183.68
0.61
(0.33%)
479.3K
XNAS Volume
XNAS 24 Dec, 2025 4:30 PM (EST)
High Financial Strength
Mid Valuation
Technically Moderately Bullish
Strong Performer, Getting Expensive
These stocks are strong in quality and technicals but have medium valuation. At somewhat expensive valuations, investors should be cautious before buying
View Similar
Embed DVM
Icon PLC Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..